CorMedix Inc (NYSE American:CRMD)

0.192
Delayed Data
As of May 18
 +0.00055 / +0.29%
Today’s Change
0.17
Today|||52-Week Range
0.78
-61.75%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$16.0M

Company Description

CorMedix, Inc. operates as pharmaceutical and medical device company that seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Bridgewater, NJ.

Contact Information

CorMedix, Inc.
400 Connell Drive
Berkeley Heights New Jersey 07921
P:(908) 517-9500
Investor Relations:

Employees

Shareholders

Other institutional7.14%
Individual stakeholders7.07%
Mutual fund holders2.78%

Top Executives

Mohammed Khoso BaluchChief Executive Officer & Director
Bob CookChief Financial Officer
Antony E. PfaffleSecretary, Chief Scientific Officer & Director
John L. ArmstrongExecutive Vice President-Technical Operations
John OrtizVP-Regulatory Affairs & Quality Assurance